Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal rhGDF-5 for Early Stage Lumbar Disc Degeneration
NCT01182337Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2010
- Primary completion
- Jun 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of gdf5 in Lumbar degenerative disc disease (DDD), sponsored by Johnson & Johnson. Started Jun 2010; status: completed.
02
Drugs
gdf5
03
Conditions
Lumbar degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT01182337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01182337.